Nachrichten zur Vertex Pharmaceuticals Aktie

With the acquisition, Vertex will add Alpines portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion…

Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the…

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in…

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Die Analysten vom Investmenthaus RBC Capital Markets trauen der Aktie von Vertex…

Vertex Pharmaceuticals executive sells shares worth over $100k…

While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of…

Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this…

…

Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.…

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

Vertex shares have climbed almost 50% over the past year.…

Vertex shares have climbed almost 50% over the past year.…

JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies are part of the Zacks top Analyst Blog.…